|
| 38009241 | A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema. | Allergy | 2024 |
| 36116748 | Review of evidence supporting the use of nasal corticosteroid irrigation for chronic rhinosinusitis. | Ann Allergy Asthma Immunol | 2023 |
| 37634580 | An updated review of pediatric autoimmune neuropsychiatric disorders associated with Streptococcus/pediatric acute-onset neuropsychiatric syndrome, also known as idiopathic autoimmune encephalitis: What the allergist should know. | Ann Allergy Asthma Immunol | 2023 |
| 38082409 | Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysis. | Allergy Asthma Clin Immunol | 2023 |
| 37557952 | Recall urticaria with infusion of agalsidase beta. | Ann Allergy Asthma Immunol | 2023 |
| 37746795 | Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat. | Clin Transl Allergy | 2023 |
| 37746794 | A concept for integrated care pathways for atopic dermatitis-A GA<sup>2</sup> LEN ADCARE initiative. | Clin Transl Allergy | 2023 |
| 37480206 | Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis. | Allergy Asthma Proc | 2023 |
| 37698716 | Efficacy of Biologics in Patients with Allergic Severe Asthma, Overall and by Blood Eosinophil Count: A Literature Review. | Adv Ther | 2023 |
| 37731491 | Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning. | Front Immunol | 2023 |
| 37574079 | Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study. | J Allergy Clin Immunol | 2023 |
| 37160610 | Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens. | J Clin Immunol | 2023 |
| 37061431 | Clinical trial of C1-INH for treatment of ACEi-induced angioedema. | Am J Emerg Med | 2023 |
| 37119496 | The One Health approach for allergic diseases and asthma. | Allergy | 2023 |
| 36948253 | A powerful tool with a narrow focus: Aiming genome-wide association studies at chronic spontaneous urticaria. | J Allergy Clin Immunol | 2023 |
| 37380071 | Chronic Urticaria and Angioedema: Masqueraders and Misdiagnoses. | J Allergy Clin Immunol Pract | 2023 |
| 37240667 | Why a Complete Response Is the Treatment Aim in Chronic Spontaneous Urticaria. | J Clin Med | 2023 |
| 37005049 | Use of patient-reported outcome measures and inflammatory biomarkers to differentiate chronic rhinosinusitis with nasal polyp endotypes: Is it feasible? | Ann Allergy Asthma Immunol | 2023 |
| 37366581 | Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy. | Allergy | 2023 |
| 37227422 | Current challenges and future opportunities in patient-focused management of hereditary angioedema: AÂ narrative review. | Clin Transl Allergy | 2023 |
| 36816598 | Latin American anaphylaxis registry. | World Allergy Organ J | 2023 |
| 36744817 | Scoping review: multiple stakeholders and child asthma management interventions. | J Asthma | 2023 |
| 36872445 | Can clinical characteristics differentiate patients with unexplained chronic cough from patients with asthma and COPD? | Allergy Asthma Proc | 2023 |
| 36774155 | An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial. | Lancet | 2023 |
| 36868261 | Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. | Lancet | 2023 |
| 36709473 | Challenges in the Use of the Treat-to-Target Strategy in Atopic Dermatitis in Latin America: A Case Series Review. | Dermatol Ther (Heidelb) | 2023 |
| 36800518 | A focused report on progestogen hypersensitivity. | Expert Rev Clin Immunol | 2023 |
| 36828083 | Nasal allergen challenge (NAC): Practical aspects and applications from an EU/US perspective-a Work Group Report of the AAAAI Rhinitis, Rhinosinusitis and Ocular Allergy Committee. | J Allergy Clin Immunol | 2023 |
| 36370881 | The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. | J Allergy Clin Immunol | 2023 |
| 34287942 | Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study. | Allergy | 2022 |
| 35551156 | Editorial: Advancements in asthma diagnosis and management: what's new? | Curr Opin Pulm Med | 2022 |
| 35769560 | Chronic Urticaria: The Need for Improved Definition. | Front Allergy | 2022 |
| 35403217 | Development of the Cold Urticaria Activity Score. | Allergy | 2022 |
| 35600836 | WAO-ARIA consensus on chronic cough - Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19. | World Allergy Organ J | 2022 |
| 35820771 | Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives. | Allergy Asthma Proc | 2022 |
| 35818154 | Accelerated/rush allergen immunotherapy. | Allergy Asthma Proc | 2022 |
| 35627309 | Benefits and Harms of Treatment and Preventive Interventions for Hereditary Angioedema: Protocol for a Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. | Genes (Basel) | 2022 |
| 35562767 | Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride. | Allergy Asthma Clin Immunol | 2022 |
| 36481045 | Chronic spontaneous urticaria guidelines: What is new? | J Allergy Clin Immunol | 2022 |
| 36440464 | Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria. | World Allergy Organ J | 2022 |
| 36927752 | [Skin reactions to the Pfizer-BioNTech vaccine for COVID-19. An Ecuadorian experience]. | Rev Alerg Mex | 2022 |
| 35870997 | Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride. | Allergy Asthma Clin Immunol | 2022 |
| 36241154 | Existing and Investigational Medications for Refractory Chronic Spontaneous Urticaria: Safety, Adverse Effects, and Monitoring. | J Allergy Clin Immunol Pract | 2022 |
| 35931363 | Assessment of Real-World Escalation to Biologics in US Patients With Asthma. | J Allergy Clin Immunol Pract | 2022 |
| 36065111 | Longitudinal experience with treatment of acquired angioedema using tranexamic acid. | Allergy Asthma Proc | 2022 |
| 35988876 | Isolated angioedema: A review of classification and update on management. | Ann Allergy Asthma Immunol | 2022 |
| 35960533 | Consider Hereditary Angioedema in the Differential Diagnosis for Unexplained Recurring Abdominal Pain. | J Clin Gastroenterol | 2022 |
| 36265977 | Air Pollution Effects in Allergies and Asthma. | Immunol Allergy Clin North Am | 2022 |
| 36254341 | Determining biomarkers for evaluation and diagnosis of hereditary angioedema. | Clin Transl Allergy | 2022 |
| 36004497 | Biologic pathways for chronic spontaneous urticaria and their regulation by benralizumab. | Allergy | 2022 |